Skip to main content
SpringerLink
Log in

Gastrointestinal Cancers in Children

  • Chapter
  • First Online:
Textbook of Gastrointestinal Oncology

  • 865 Accesses

Abstract

Gastrointestinal system (GIS) malignancies in children are rare. They can arise from lymphoid, epithelial, blastemal, and mesenchymal origins. They all represent less than 5% of pediatric neoplasm, but the true incidence is not well known because of the rarity of these tumors and different referral patterns. Primary gastrointestinal lymphoma is the most common GI malignancy. The frequency of hepatic tumors among childhood malignancies is 0.6–1.5%. Others including stomach, pancreas, colorectal, carcinoid, and gastrointestinal stromal tumors have a lower incidence rates. This chapter aims to provide an overview of the liver and gastrointestinal tract malignancies in children.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Smith MA, Seibel NL, Altekruse SF, Ries LA, Melbert DL, O’Leary M, et al. Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol. 2010;28(15):2625–34.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Kutluk MT, Yeşilipek A. Turkish national pediatric cancer registry 2002–2008 (Turkish pediatric oncology group and Turkish pediatric hematology society). J Clin Oncol. 2013;31(suppl):abstr 10067.

    Google Scholar 

  3. Perilongo G, Shafford E, Plaschkes J. SIOPEL trials using preoperative chemotherapy in hepatoblastoma. Lancet Oncol. 2000;1:94–100.

    Article  CAS  PubMed  Google Scholar 

  4. Darbari A, Sabin KM, Shapiro CN, Schwartz KB. Epidemiology of primary hepatic malignancies in U.S. children. Hepatology. 2003;38(3):560–6.

    Article  PubMed  Google Scholar 

  5. Mann JR, Kasthuri N, Raafat F, Pincott JR, Parkes SE, Muir KR, et al. Malignant hepatic tumours in children: incidence, clinical features and aetiology. Paediatr Perinat Epidemiol. 1990;4(3):276–89.

    Article  CAS  PubMed  Google Scholar 

  6. Kassira N, Pedroso FE, Cheung MC, Koniaris LG, Sola JE. Primary gastrointestinal tract lymphoma in the pediatric patient: review of 265 patients from seer registry. J Pediatr Surg. 2011;46:1956–64.

    Article  PubMed  Google Scholar 

  7. Brecht IB, Schneider DT, Kloppel G, von Schweinitz D, Barthlen W, Hamre MR. Malignant pancreatic tumors in children and young adults: evaluation of 228 patients identified through the Surveillance, Epidemiology, and End Result (SEER) database. Klin Padiatr. 2011;223(6):341–5.

    Article  CAS  PubMed  Google Scholar 

  8. Saab R, Furman WL. Epidemiology and management options for colorectal cancer in children. Paediatr Drugs. 2008;10(3):177–92.

    Article  PubMed  Google Scholar 

  9. Kravarusic D, Feigin E, Dlugy E, Steinberg R, Baazov A, Erez I, et al. Colorectal carcinoma in childhood: a retrospective multicenter study. J Pediatr Gastroenterol Nutr. 2007;44(2):209–11.

    Article  PubMed  Google Scholar 

  10. Oberg K. Diagnosis and treatment of carcinoid tumors. Expert Rev Anticancer Ther. 2002;3:863–77.

    Article  Google Scholar 

  11. Ding L, Yin Y, Han L, Li Y, Zhao J, Zhang W. TSC1-mTOR signaling determines the differentiation of islet cells. J Endocrinol. 2017 Jan;232(1):59–70.

    Article  CAS  PubMed  Google Scholar 

  12. Miettinen M, Lasota J. Gastrointestinal Stromal Tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics. Pol J Pathol. 2003;54(1):3–24.

    PubMed  Google Scholar 

  13. Pickett LK, Briggs HC. Cancer of the gastrointestinal tract in childhood. Pediatr Clin N Am. 1967;14:223–34.

    Article  CAS  Google Scholar 

  14. Bethel CAI, Bhattacharyya N, Hutchinson C, Ruymann F, Cooney DR. Alimentary tract malignancies in children. J Pediatr Surg. 1997;32:1004–9.

    Article  CAS  PubMed  Google Scholar 

  15. Ladd AP, Grossfeld JL. Gastrointestinal tumors in children and adolescents. Semin Pediatr Surg. 2006;15:37–47.

    Article  PubMed  Google Scholar 

  16. Kutluk T, Yalcin B, Ekinci S, Kale G, Akyuz C, Aydin B, et al. Primary liver tumors in children: Hacettepe experience. Turk J Pediatr. 2014;56:1–10.

    PubMed  Google Scholar 

  17. Stocker JT. Hepatic tumors in children. Clinics Liver Dis. 2001;5:259–81.

    Article  CAS  Google Scholar 

  18. Weinberg AG, Finegold MJ. Primary hepatic tumors of childhood. Hum Pathol. 1983;14:512–37.

    Article  CAS  PubMed  Google Scholar 

  19. Agarwala S. Primary malignant liver tumors in children. Indian J Pediatr. 2012;79(6):793–800.

    Article  PubMed  Google Scholar 

  20. Schnater JM, Kohler SE, Lamers WH, Von Schweinitz D, Aronson DC. Where do we stand with hepatoblastoma? Cancer. 2003;98:668–78.

    Article  CAS  PubMed  Google Scholar 

  21. Pham TH, Iqbal CW, Grams JM, Zarroug AE, Wall JC, Ishitani MB, et al. Outcomes of primary liver cancer in children: an appraisal of experience. J Pediatr Surg. 2007;42(5):834–9.

    Article  PubMed  Google Scholar 

  22. Turcotte LM, Georgieff MK, Ross JA, Feusner JH, Tomlinson GE, Maglogolowkin MH, et al. Neonatal medical exposures and characteristics of low birth weight hepatoblastoma cases: a report from the Children’s Oncology Group. Pediatr Blood Cancer. 2014;61(11):2018–23.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Meyers R, Aronson DC, Von Schweinitz D, Zimmermann A, Malogolowkin MH. Pediatric liver tumors. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. 6th ed. Philadephia: Wolters Kluwer and Lippincott Williams; 2011.

    Google Scholar 

  24. Ehrlich P, Greenberg M, Filler RM. Improved long term survival with preoperative chemotherapy for hepatoblastoma. J Pediatr Surg. 1997;32:999–1003.

    Article  CAS  PubMed  Google Scholar 

  25. Weinblatt M, Siegel S, Siegel M, Stanley P, Weitzman JJ. Preoperative chemotherapy for unresectable primary hepatic malignancy in children. Cancer. 1982;50:1031–4.

    Article  Google Scholar 

  26. De Ioris M, Brugieres L, Zimmermann A, Keeling JW, Brock P, Maibach R, et al. Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience. Eur J Cancer. 2008;44:545–50.

    Article  CAS  PubMed  Google Scholar 

  27. Miller J, Greenspan B. Integrated imaging of hepatic tumors in children: I. Malignant lesions (primary and metastatic). Radiology. 1985;145:83–90.

    Google Scholar 

  28. Perilongo G, Brown J, Shafford E, Brock P, De Camargo B, Keeling JW, et al. Hepatoblastoma presenting with lung metastases. Cancer. 2000;89:1845–53.

    Article  CAS  PubMed  Google Scholar 

  29. Maruyama K, Ikeda H, Koizumi T, Tsuchida Y, Tanimura M, Nishida H, et al. Case-control study of perinatal factors and hepatoblastoma in children with extremely low birth weight. Pediatr Int. 2000;42:492–8.

    Article  CAS  PubMed  Google Scholar 

  30. Hiyama E, Yamaoka H, Matsunaga T, Hayashi Y, Ando H, Suita S, et al. High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma. Br J Cancer. 2004;91:972–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Chitraghar S, Iyer VK, Agarwala S, DattaGupta S, Sharma A, Wari MN. Loss of heterozygosity on chromosome 11p15.5 and relapse in hepatoblastoma. Eur J Pediatr Surg. 2011;21:50–3.

    Article  Google Scholar 

  32. Litten JB, Tomlinson GE. Liver tumors in children. Oncologist. 2008;13(7):812–20.

    Article  PubMed  Google Scholar 

  33. Nathan JD, Ryckman FC, Alonso MH, Tiao G. Transplantation for hepatic malignancy in children. In: Bussuttil RW, Klintmalm GBG, editors. Transplantation of the liver. 3rd ed. Philadelphia: Elsevier Saunders; 2015. p. 346–58.

    Chapter  Google Scholar 

  34. Roebuck DJ, Aronson D, Clapuyt P, Czauderna P, De Ville De Goyet J, Gauthier F, et al. 2005 pretext: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group. Pediatr Radiol. 2007;37:123–32.

    Article  PubMed  Google Scholar 

  35. Meyers RL, Tiao G, de Ville de Goyet J, Superina R, Aronson DC. Hepatoblastoma state of the art: pre-treatment extent of disease, surgical resection guidelines and the role of liver transplantation. Curr Opin Pediatr. 2014;26(1):29–36.

    Article  CAS  PubMed  Google Scholar 

  36. Meyers RL, Aronson DC, Zimmermann A. Malignant liver tumors. In: CA G, Adzick NS, Krummel TM, Laberge JM, Shamberger R, Caldamone A, editors. Pediatric surgery. Philadelphia: Saunders, an imprint of Elsevier Inc.; 2012. p. 463–82.

    Chapter  Google Scholar 

  37. Aronson DC, Czauderna P, Maibach R, Perilongo G, Morland B. The treatment of hepatoblastoma: its evolution and the current status as per the SIOPEL trials. J Indian Assoc Pediatr Surg. 2014;19(4):201–7.

    Article  PubMed  PubMed Central  Google Scholar 

  38. SIOPEL. SIOPEL guidelines for the treatment of hepatoblastoma. 2018; Available from: http://www.siopel.org/?q=node/157.

  39. Czauderna P, Otte JB, Aronson DC, Gauthier F, Mackinlay G, Roebuck D, et al. Childhood liver tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL). Guidelines for surgical treatment of hepatoblastoma in the modern era–recommendations from the childhood liver tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL). Eur J Cancer. 2005;41:1031–6.

    Article  PubMed  Google Scholar 

  40. Zsiros J, Brugieres L, Brock P, Roebuck DJ, Maibach R, Zimmermann A, et al. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study. Lancet Oncol. 2013;14(9):834–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Perilongo G, Maibach R, Shafford E, Brugieres L, Brock P, Morland B, et al. Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma. N Engl J Med. 2009;22(361):1662–70.

    Article  Google Scholar 

  42. Schnater JM, Aronson DC, Plaschkes J, Perilongo G, Brown J, Otte JB, et al. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group. Cancer. 2002;94:1111–20.

    Article  PubMed  Google Scholar 

  43. Anonymous. Risk-based therapy in treating younger patients with newly diagnosed liver cancer. Available from: https://www.clinicaltrials.gov/ct2/show/NCT00980460.

  44. Von Schweinitz D, Haberle B. German liver tumor study: Hb 99. First International Symposium Childhood Hepatoblastoma; Poland, Gdansk, 2007.

    Google Scholar 

  45. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med. 1997;336(26):1855–9.

    Article  CAS  PubMed  Google Scholar 

  46. Chen DS. Hepatitis B vaccination: the key towards elimination and eradication of hepatitis B. J Hepatol. 2009;50(4):805–16.

    Article  PubMed  Google Scholar 

  47. Hadley GP, Govender D, Landers G. Primary tumors of the liver in children: an African perspective. Pediatr Surg Int. 2004;20:314–8.

    Article  CAS  PubMed  Google Scholar 

  48. Czauderna P, MacKinley G, Perilongo G, Brown J, Shafford E, Aronson D, et al. Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology Group. J Clin Oncol. 2002;20:2798–804.

    Article  CAS  PubMed  Google Scholar 

  49. Zimmermann A. Hepatoblastoma with cholangioblastic features (‘cholangioblastic hepatoblastoma’) and other liver tumors with bimodal differentiation in young patients. Med Pediatr Oncol. 2002;39:487–91.

    Article  PubMed  Google Scholar 

  50. Grosfeld JL, Otte JB. Liver tumors in children. In: Carcahi R, Grosfeld JL, Azmy AF, editors. The surgery of childhood tumors. 2nd ed:. Berlin, Heidelberg: Springer; 2008. p. 227–226A.

    Google Scholar 

  51. Sangiovanni A, Manini MA, Iavarone M, Romeo R, Forzenigo LV, Fraquelli M, et al. The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis. Gut. 2010;59(5):638–44.

    Article  PubMed  Google Scholar 

  52. Anonymous. Childhood cancer by the ICCC. In: Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, et al., editors. Seer cancer statistics review, 1975–2012 (vintage 2009 populations). Bethesda: National Cancer Instute; 2012.

    Google Scholar 

  53. Yu SB, Kim HY, Eo H, Won JK, Jung SE, Park KW, et al. Clinical characteristics and prognosis of pediatric hepatocellular carcinoma. World J Surg. 2006;30:43–50.

    Article  PubMed  Google Scholar 

  54. Schmid I, von Schweinitz D. Pediatric hepatocellular carcinoma: challenges and solutions. J Hepatocell Carcinoma. 2017;4:15–21.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Katzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Liu-Mares W, Douglas EC, et al. Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children’s Cancer Group Intergroup Study. J Clin Oncol. 2002;20(12):2789–97.

    Article  PubMed  Google Scholar 

  56. Hawkins CM, Kukreja K, Geller JI, Schatzman C, Ristagno R. Radioembolisation for treatment of pediatric hepatocellular carcinoma. Pediatr Radiol. 2013;43(7):876–81.

    Article  PubMed  Google Scholar 

  57. Kim JM, Kwon CH, Joh JW, Kim SJ, Shin M, Kim EY, et al. Patients with unresectable hepatocellular carcinoma beyond Milan criteria: should we perform transarterial chemoembolization or liver transplantation? Transplant Proc. 2010;42(3):821–4.

    Article  CAS  PubMed  Google Scholar 

  58. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19(3):329–38.

    Article  CAS  PubMed  Google Scholar 

  59. Oschlies I, Klapper W, Zimmermann M, Krams M, Wacker HH, Burkhardt B, et al. Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) multicenter trial. Blood [Multicenter Study Research Support, Non-U.S. Gov’t]. 2006;107(10):4047–52.

    CAS  Google Scholar 

  60. Jaffe E, Harris NL, Stein H, et al. Introduction and overview of the classification of the lymphoid neoplasms. In: Swerdlow S, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. International Agency for Research on Cancer: Lyon; 2008. p. 157–66.

    Google Scholar 

  61. Radman I, Kovacevic-Metelko J, Aurer I, Nemet D, Zupancic-Salek S, Bogdanic V, et al. Surgical resection in the treatment of primary gastrointestinal non-Hodgkin’s lymphoma: retrospective study. Croat Med J. 2002;43:555–60.

    PubMed  Google Scholar 

  62. Bethel CA, Bhattacharyya N, Hutcinson C, Ruymann F, Cooney DR. Alimentary malignancies in children. J Pediatr Surg. 1997;32:1004–8.

    Article  CAS  PubMed  Google Scholar 

  63. Smets F, Sokal EM. Lymphoproliferation in children after liver transplantation. J Pediatr Gastroenterol Nutr. 2002;34:499–505.

    Article  PubMed  Google Scholar 

  64. Purtillo DT, DeFlorio D, Hutt LM, Bhawan J, Yang JPS, Otto R, et al. Variable phenotype expression of an X-linked lymphoproliferative syndrome. N Engl J Med. 1977;297:1077–80.

    Article  Google Scholar 

  65. Pricolol VE, Mangi AA, Aswad B, Bland KI. Gastrointestinal malignancies in patients with celiac sprue. Am J Surg. 1998;176:344–7.

    Article  Google Scholar 

  66. Morsi A, Abd El-Ghani Ael G, El-Shafiey M, Fawzy M, Ismail H, Monir M. Clinico-pathological features and outcome of management of pediatric gastrointestinal lymphoma. J Egypt Natl Canc Inst. 2005;17(4):251–9.

    PubMed  Google Scholar 

  67. Percy CL, Smith MA, Linet M, et al. Cancer incidence and survival among children and adolescents: United States seer program 1975–1995. Bethesda: National Cancer Institute; 1999.

    Google Scholar 

  68. Salzburg J, Burkhardt B, Zimmermann M, Wachowski O, Woessmann W, Oschlies I, et al. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin’s lymphoma differ by non-Hodgkin’s lymphoma subtype: a Berlin-Frankfurt-Munster Group report. J Clin Oncol. 2007;25(25):3915–22.

    Article  PubMed  Google Scholar 

  69. Guillerman RP. Primary intestinal non-Hodgkin lymphoma. J Pediatr Hematol Oncol. 2000;22:476–8.

    Article  CAS  PubMed  Google Scholar 

  70. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17(12):3835–49.

    Article  CAS  PubMed  Google Scholar 

  71. Murphy SB. Classification, staging and end results of treatment of childhood non-Hodgkin’s lymphomas: dissimilarities from lymphomas in adults. Semin Oncol. 1980;7(3):332–9.

    CAS  PubMed  Google Scholar 

  72. Bandyopadhyay R, Sinha SK, Chatterjee U, Nag D, Mukhopadhyay S, Chowdhury SR, et al. Primary pediatric gastrointestinal lymphoma. Indian J Med Paediatr Oncol. 2011;32(2):92–5.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Patte C, Auperin A, Gerrard M, Michon J, Pinkerton R, Sposto R, et al. Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Blood [Multicenter Study Randomized Controlled Trial Research Support, NIH, Extramural Research Support, Non-US Gov’t]. 2007;109(7):2773–80.

    CAS  Google Scholar 

  74. Patte C, Auperin A, Michon J, Behrendt H, Leverger G, Frappaz D, et al. The Societe Francaise d’Oncologie Pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood [Clinical Trial Research Support, Non-U.S. Gov’t]. 2001;97(11):3370–9.

    CAS  Google Scholar 

  75. Woessmann W, Seidemann K, Mann G, Zimmermann M, Burkhardt B, Oschlies I, et al. The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95. Blood [Clinical Trial Randomized Controlled Trial Research Support, Non-U.S. Gov’t]. 2005;105(3):948–58.

    CAS  Google Scholar 

  76. Issaivanan M, Redner A, Weinstein T, Soffer S, Glassman L, Edelman M, et al. Esophageal carcinoma in children and adolescents. J Pediatr Hematol Oncol. 2012;34(1):63–7.

    Article  PubMed  Google Scholar 

  77. Kaye M, Willie R. Caustic ingestions in children. Curr Opin Pediatr. 2009;21:651–4.

    Article  Google Scholar 

  78. Daly JM, Fry WA, Little AG, Winchester DP, McKee RF, Stewart AK, et al. Esophageal cancer: results of an American College of Surgeons Patient Care Evaluation Study. J Am Coll Surg. 2000;190:562–72.

    Article  CAS  PubMed  Google Scholar 

  79. McNamara MJ, Adelstein DJ. Current developments in the management of locally advanced esophageal cancer. Curr Oncol Rep. 2012;14(4):342.

    Article  CAS  PubMed  Google Scholar 

  80. Amin MB, Edge S, Greene FL, Byrd DR, Brookland RK, Washington MK, et al., editors. AJCC cancer staging manual. 8th ed. NewYork: Springer; 2017.

    Google Scholar 

  81. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349:2241–52.

    Article  CAS  PubMed  Google Scholar 

  82. Harting MT, Blakely ML, Herzog CE, Lally KP, Ajani JA, Andrassy RJ. Treatment issues in pediatric gastric adenocarcinoma. J Pediatr Surg. 2004;39(8):e8–10.

    Article  PubMed  Google Scholar 

  83. Milne AN, Carneiro F, O’Morain C, Offerhaus GJ. Nature meets nurture: molecular genetics of gastric cancer. Hum Genet. 2009;126(5):615–28.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Chang VY, Federman N, Martinez-Agosto J, Tatishchev SF, Nelson SF. Whole exome sequencing of pediatric gastric adenocarcinoma reveals an atypical presentation of Li-Fraumeni syndrome. Pediatr Blood Cancer. 2013;60(4):570–4.

    Article  PubMed  Google Scholar 

  85. Ychou M, Duffour J, Kramar A, Gourgou S, Grenier J. Clinical significance and prognostic value of CA72-4 compared with CEA and ca19-9 in patients with gastric cancer. Dis Markers. 2000;16(3–4):105–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Mlkvy P. Multimodal therapy of gastric cancer. Dig Dis. 2010;28(4–5):615–8.

    Article  PubMed  Google Scholar 

  87. Varadhachary G, Ajani JA. Preoperative and adjuvant therapies for upper gastrointestinal cancers. Expert Rev Anticancer Ther. 2005;5(4):719–25.

    Article  CAS  PubMed  Google Scholar 

  88. Ajani JA. Current status of therapy for advanced gastric carcinoma. Oncology. 1998;12(8 Suppl 6):99–102.

    CAS  PubMed  Google Scholar 

  89. Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (spirits trial): a phase III trial. Lancet Oncol. 2008;9(3):215–21.

    Article  CAS  PubMed  Google Scholar 

  90. Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E. Gastric cancer. Crit Rev Oncol Hematol. 2009;71(2):127–64.

    Article  PubMed  Google Scholar 

  91. Hsieh L, Burjonrappa S. Pediatric pancreatic tumors: a review of current concepts. JOP J Pancreas (Online). 2016;17(3):257–62.

    Google Scholar 

  92. Rojas Y, Warneke CL, Dhamne CA, Tsao K, Nuchtern JG, Lally KP, et al. Primary malignant pancreatic neoplasms in children and adolescents: a 20 year experience. J Pediatr Surg [Comparative Study Multicenter Study]. 2012;47(12):2199–204.

    Google Scholar 

  93. Glick RD, Pashankar FD, Pappo A, Laquaglia MP. Management of pancreatoblastoma in children and young adults. J Pediatr Hematol Oncol. 2012;34(Suppl 2):S47–50.

    Article  CAS  PubMed  Google Scholar 

  94. Klimstra DS, Wenig BM, Adair CF, Heffess CS. Pancreatoblastoma. A clinicopathologic study and review of the literature. Am J Surg Pathol. 1995;19(12):1371–89.

    Article  CAS  PubMed  Google Scholar 

  95. McWilliams RR, Wieben ED, Rabe KG, Pedersen KS, Wu Y, Sicotte H, et al. Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling. Eur J Hum Genet [Research Support, N.I.H., Extramural]. 2011 Apr;19(4):472–8.

    Article  CAS  Google Scholar 

  96. Hoerner MT. Carcinoma of the colon and rectum in persons under 20 years of age. Am J Surg. 1958;96:47–53.

    Article  CAS  PubMed  Google Scholar 

  97. Fitzgibbons RJ, Lynch HT, Stanislav GV, Watson PA, Lanspa SJ, Marcus JN, et al. Recognition and treatment of patients with hereditary nonpolyposis colon cancer (Lynch syndromes I and II). Ann Surg. 1987;206(3):289–95.

    Article  PubMed  PubMed Central  Google Scholar 

  98. Aiges HW, Kahn E, Silverberg M, Daum F. Adenocarcinoma of the colon in an adolescent with the family cancer syndrome. J Pediatr. 1979;94:632–3.

    Article  CAS  PubMed  Google Scholar 

  99. Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology. 2003;124:544–60.

    Article  PubMed  Google Scholar 

  100. Hamilton SR, Vogelstein B, Kudo S, Riboli E, Nakamura S, Hainaut P, et al. In: Hamilton SR, Aaltonen LA, editors. Tumors of the colon and rectum. Lyon: IARC Press; 2000.

    Google Scholar 

  101. Akyuz C, Buyukcam A, Orhan D, Kutluk T, Yalcin B, Varan A, et al. K-RAS mutation and colorectal carcinoma in childhood. Pediatr Blood Cancer. 2012;59(6):965–1152.

    Article  Google Scholar 

  102. Pappo A, Rodriguez-Galindo C, Furman W. Management of infrequent cancers of childhood. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. 6th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2011. p. 1098–123.

    Google Scholar 

  103. Hill DA, Furman WL, Billups CA, Riedley SE, Cain AM, Rao BN, et al. Colorectal carcinoma in childhood and adolescence: a clinicopathologic review. J Clin Oncol. 2007;25(36):5808–14.

    Article  PubMed  Google Scholar 

  104. Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology. 2010;138(6):2073–87.

    Article  CAS  PubMed  Google Scholar 

  105. Sultan I, Rodriguez-Galindo C, El-Taani H, Pastore G, Casanova M, Gallino G, et al. Distinct features of colorectal cancer in children and adolescents: a population-based study of 159 cases. Cancer. 2010;116(3):758–65.

    Article  PubMed  Google Scholar 

  106. Karnak I, Ciftci AO, Senocak ME, Buyukpamukcu N. Colorectal carcinoma in children. J Pediatr Surg. 1999;34:1499–504.

    Article  CAS  PubMed  Google Scholar 

  107. Ferrari A, Rognone A, Casanova M, Zaffignani E, Piva L, Collini P, et al. Colorectal carcinoma in children and adolescents: the experience of the Istituto Nazionale Tumori of Milan, Italy. Pediatr Blood Cancer. 2008;50(3):588–93.

    Article  PubMed  Google Scholar 

  108. Andersson A, Bergdahl L. Carcinoma of the colon in children: a report of six new cases and review of the literature. J Pediatr Surg. 1976;11:967–71.

    Article  CAS  PubMed  Google Scholar 

  109. Lin JT, Wang WS, Yen CC, Liu JH, Yang MH, Chao TC, et al. Outcome of colorectal carcinoma in patients under 40 years of age. J Gastoent Hepatol. 2005;20:900–5.

    Article  Google Scholar 

  110. Bleyer A, Barr R, Hayes-Lattin B, Thomas D, Ellis C, Anderson B, et al. The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer. 2008;8(4):288–98.

    Article  CAS  PubMed  Google Scholar 

  111. Shah N, Sasikumar P, Rajkumar JS. Single incision laparoscopic surgery-trans anal endoscopic microsurgery: a technological innovation. J Minim Access Surg. 2014;10(2):99–101.

    Article  PubMed  PubMed Central  Google Scholar 

  112. Compton CC. Colorectl carcinoma: diagnostic, prognostic, and molecular features. Mod Pathol. 2003;16(4):376–88.

    Article  PubMed  Google Scholar 

  113. Zaniboni A, Labianca R, Gruppo Italiano per lo Studio e la Cura dei Tumori del D. Adjuvant therapy for stage II colon cancer: an elephant in the living room? Ann Oncol. 2004;15(9):1310–8.

    Article  CAS  PubMed  Google Scholar 

  114. Network NCC. Colon cancer version 2.2015. Clinical paractice guidelines in oncology (NCCCN guidelines); 2014 [cited 2014]; Available from: www.nccn.org.

  115. Devaud N, Gallinger S. Chemotherapy of MMR-deficient colorectal cancer. Farm Cancer. 2013;12(2):301–6.

    Article  CAS  Google Scholar 

  116. Minsky BD, Cohen AM, Enker WE, Kelsen DP, Kemeny N, Frankel J. Efficacy of postoperative 5-FU, high-dose leucovorin, and sequential radiation therapy for clinically resectable rectal cancer. Cancer Investig. 1995;13(1):1–7.

    Article  CAS  Google Scholar 

  117. Minsky BD, Cohen AM, Enker WE, Sigurdson E. Phase I/II trial of pre-operative radiation therapy and coloanal anastomosis in distal invasive resectable rectal cancer. Int J Radiat Oncol Biol Phys. 1992;23(2):387–92.

    Article  CAS  PubMed  Google Scholar 

  118. Kulke MH, Mayer RJ. Carcinoid tumors. N Engl J Med. 2005;340(11):858.

    Article  Google Scholar 

  119. Neves GR, Chapchap P, Sredni ST, Viana CR, Mendes WL. Childhood carcinoid tumors: description of a case series in a Brazilian Cancer Center. 2006;124(1):21–5.

    Google Scholar 

  120. Spunt SL, Pratt CB, Rao BN. Childhood carcinoid tumors: the St Jude Children’s Research Hospital experience. J Pediatr Surg. 2000;35(9):1282–6.

    Article  CAS  PubMed  Google Scholar 

  121. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35825 cases in the United States. J Clin Oncol. 2008;26(18):3063.

    Article  PubMed  Google Scholar 

  122. Boxberger N, Redlich A, Boger C, Leuschner I, von Schweinitz D, Dralle H, et al. Neuroendocrine tumors of the appendix in children and adolescents. Pediatr Blood Cancer. 2013;60(1):65–70.

    Article  PubMed  Google Scholar 

  123. Maggard MA, O’Connell JB, Ko CY. Updated population-based review of carcinoid tumors. Ann Surg. 2004;240(1):117.

    Article  PubMed  PubMed Central  Google Scholar 

  124. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97:934–59.

    Article  PubMed  Google Scholar 

  125. Williams ED, Sandler M. The classification of carcinoid tumours. Lancet. 1963;1(7275):238.

    Article  CAS  PubMed  Google Scholar 

  126. Kvols LK. Metastatic carcinoid tumors and the malignant carcinoid syndrome. Ann N Y Acad Sci. 1994;733:464.

    Article  CAS  PubMed  Google Scholar 

  127. Dall’Igna P, Ferrari A, Luzzatto C, Bisogno G, Casanova M, Alaggio R, et al. Carcinoid tumor of the appendix in childhood: the experience of two Italian Institutions. JPGN. 2005;40:216–9.

    PubMed  Google Scholar 

  128. Feldman JM. Carcinoid tumors and syndrome. Semin Oncol. 1987;14(3):237.

    CAS  PubMed  Google Scholar 

  129. Çoşkun H, Bostancı O, Dilege ME, et al. Carcinoid tumors of appendix. Treatment and outcome. Ulus Travma Acil Cerrahi Derg. 2006;12:150–4.

    PubMed  Google Scholar 

  130. Anonymous. Neoplasms of the neuroendocrine pancreas. In: Lloyd RV, Osamura RY, Klöppel G, Rosai J, editors. WHO classification of tumours of endocrine organs. 4th ed. Lyon: International Agency for Research on Cancer; 2017. p. 209–40.

    Google Scholar 

  131. Rindi G, Arnold R, Bosman FT. Nomenclature and classification of neuroendocrine neoplasms of the digestive system. In: Bosman TF, Carneiro F, Hruban RH, Theise ND, editors. WHO classification of tumors of the digestive system. Lyon: International Agency for Research on Cancer (IARC); 2010. p. 13.

    Google Scholar 

  132. Oberg K. Carcinoid tumors: molecular genetics, tumor biology, and update of diagnosis and treatment. Curr Opin Oncol. 2002;14:38–45.

    Article  CAS  PubMed  Google Scholar 

  133. Granberg D, Wilander E, Oberg K, Skogseid B. Prognostic markers in patients with typical bronchial carcinoid tumors. J Clin Endocrinol Metab. 2000;85:3425–30.

    CAS  PubMed  Google Scholar 

  134. Yachida S, Vakiani E, White CM, Zhong Y, Saunders T, Morgan R, et al. Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors. Am J Surg Pathol. 2012;36(2):173–84.

    Article  PubMed  PubMed Central  Google Scholar 

  135. Howell DL, O’Dorisio MS. Management of neuroendocrine tumors in children, adolescents, and young adults. J Pediatr Hematol Oncol. 2012;34(Suppl 2):S64–8.

    Article  PubMed  Google Scholar 

  136. Shebani KO, Souba WW, Finkelstein DM, Stark PC, Elgadi KM, Tanabe KK, et al. Prognosis and survival in patients with gastrointestinal tract carcinoid tumors. Ann Surg. 1999;229(6):815–21; discussion 822–813.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  137. Mani S, Modlin IM, Ballantyne G, Ahlman H, West B. Carcinoids of the rectum. J Am Coll Surg. 1994;179(2):231–48.

    CAS  PubMed  Google Scholar 

  138. de Mestier L, Brixi H, Gincul R, Ponchon T, Cadiot G. Updating the management of patients with rectal neuroendocrine tumors. Endoscopy. 2013;45(12):1039–46.

    Article  PubMed  Google Scholar 

  139. Jensen RT, Cadiot G, Brandi ML, de Herder WW, Kaltsas G, Komminoth P, et al. ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. Neuroendocrinology. 2012;95(2):98–119.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  140. Cloyd JM, Poultsides GA. Non-functional neuroendocrine tumors of the pancreas: advances in diagnosis and management. World J Gastroenterol. 2015;21(32):9512–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  141. More J, Young J, Reznik Y, Raverot G, Borson-Chazot F, Rohmer V, et al. Ectopic ACTH syndrome in children and adolescents. J Clin Endocrinol Metab. 2011;96(5):1213–22.

    Article  CAS  PubMed  Google Scholar 

  142. Stiller C. Childhood cancer in Britain: incidence, survival and mortality. New York: Oxford University Press Inc; 2007. 104 p.

    Book  Google Scholar 

  143. Pappo AS, Janeway K, Laquaglia M, Kim SY. Special considerations in pediatric gastrointestinal tumors. J Surg Oncol. 2011;104(8):928–32.

    Article  PubMed  Google Scholar 

  144. DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg. 2000;231(1):51–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  145. Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol. 2005;29(1):52–68.

    Article  PubMed  Google Scholar 

  146. Miettinen M, Makhlouf H, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am J Surg Pathol. 2006;30(4):477–89.

    Article  PubMed  Google Scholar 

  147. Cypriano MS, Jenkins JJ, Pappo AS, Rao BN, Daw NC. Pediatric gastrointestinal stromal tumors and leiomyosarcoma. Cancer. 2004;101(1):39–50.

    Article  PubMed  Google Scholar 

  148. Pappo AS, Janeway KA. Pediatric gastrointestinal stromal tumors. Hematol Oncol Clin North Am. 2009;23(1):15–34, vii.

    Article  PubMed  Google Scholar 

  149. Benesch M, Leuschner I, Wardelmann E, Thielen M, Schmid I, Kontny U, et al. Gastrointestinal stromal tumours in children and young adults: a clinicopathologic series with long-term follow-up from the database of the Cooperative Weichteilsarkom Studiengruppe (CWS). Eur J Cancer. 2011;47(11):1692–8.

    Article  PubMed  Google Scholar 

  150. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, et al. Gain of function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998;279:577–80.

    Article  CAS  PubMed  Google Scholar 

  151. Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N, et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science. 2003;299(5607):708.

    Article  CAS  PubMed  Google Scholar 

  152. Heinrich MC, Corless CL, Demetri GD, Blanke CD, von Mehren M, Joensuu H, et al. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol. 2003;21:4342–9.

    Article  CAS  PubMed  Google Scholar 

  153. Janeway KA, Kim SY, Lodish M, Nose V, Rustin P, Gaal J, et al. Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking kit and PDGFRA mutation. Proc Natl Acad Sci U S A. 2010;108(1):314–8.

    Article  PubMed  PubMed Central  Google Scholar 

  154. Pantaleo MA, Astolfi A, Indio V, Moore R, Thiessen N, Heinrich MC, et al. SDHA loss of function mutations in kit-PDGFRA wild type gastrointestinal stromal tumors identified by massively parallel sequencing. J Natl Cancer Inst. 2011;103(12):983–7.

    Article  CAS  PubMed  Google Scholar 

  155. Burnichon N, Briere JJ, Libe R, Vescovo L, Riviere J, Tissier F, et al. SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet. 2010;19(15):3011–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  156. Tarn C, Rink L, Merkel E, Flieder D, Pathak H, Koumbi D, et al. Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors. Proc Natl Acad Sci U S A. 2008;105(24):8387–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  157. Stratakis CA, Carney JA. The triad of paragangliomas, gastric stromal tumors and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications. J Intern Med. 2009;266(1):43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  158. Maeyama H, Hidaka E, Minami S, Kajiyama M, Kurais A, Mori H, et al. Familial gastrointestinal stromal tumor with hyperpigmentation: association with germline mutation of the c-kit gene. Gastroenterology. 2001;120(1):210.

    Article  CAS  PubMed  Google Scholar 

  159. Agaimy A, Markl B, Arnholdt H, Hartmann A, Scheneider-Stock R, Chetty R. Sporadic segmental interstitial cell of Cajal hyperplasia (microscopic GIST) with unusual diffuse longitudinal growth replacing the muscularis propria: differential diagnosis to hereditary gist syndromes. Int J Clin Exp Pathol. 2010;3(5):549–56.

    CAS  PubMed  PubMed Central  Google Scholar 

  160. Miettinen M, Fetsch JF, Sobin LH, Lasota J. Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases. Am J Surg Pathol. 2006;30(1):90.

    Article  PubMed  Google Scholar 

  161. Mussi C, Schildhaus HU, Gronchi A, Wardelmann E, Hohenberger P. Therapeutic consequences from molecular biology for gastrointestinal stromal tumor patients affected by neurofibromatosis type 1. Clin Cancer Res. 2008;14(14):4550.

    Article  CAS  PubMed  Google Scholar 

  162. Wang JH, Lasota J, Miettinen M. Succinate Dehydrogenase Subunit B (SDHB) is expressed in neurofibromatosis 1-associated Gastrointestinal Stromal Tumors (GISTS): implications for the SDHB expression based classification of GISTS. J Cancer. 2011;16(2):90–3.

    Article  Google Scholar 

  163. Janeway KA, Pappo A. Treatment guidelines for gastrointestinal stromal tumors in children and young adults. J Pediatr Hematol Oncol. 2012;34(Suppl 2):S69.

    Article  CAS  PubMed  Google Scholar 

  164. Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol. 2006;23(2):70.

    Article  PubMed  Google Scholar 

  165. Miettinen M, Lasota J, Sobin LH. Gastrointestinal stromal tumors of the stomach in children and young adults: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases with long-term follow-up and review of the literature. Am J Surg Pathol. 2005;29:1373–81.

    Article  PubMed  Google Scholar 

  166. Agaram NP, Laquaglia MP, Ustun B, Guo T, Wong GC, Socci ND, et al. Molecular characterization of pediatric gastrointestinal stromal tumors. Clin Cancer Res. 2008;14:3204–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  167. Nilsson B, Bumming P, Meis-Kindblom JM, Oden A, Dortok A, Gustavsson B, et al. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era-a population-based study in western Sweden. Cancer. 2005;103:821–9.

    Article  PubMed  Google Scholar 

  168. Fletcher CDM, Berman JJ, Corless CL, Gorstein F, Lasota J, Longley BJ, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002;33(5):459–65.

    Article  PubMed  Google Scholar 

  169. Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol. 2008;39:1411.

    Article  PubMed  Google Scholar 

  170. Watson RR, Binmoeller KF, Hemerski CM, Shergill AK, Shaw RE, Jaffee IM, et al. Yield and performance characteristics of endoscopic ultrasound-guided fine needle aspiration for diagnosing upper GI tract stromal tumors. Dig Dis Sci. 2011;56(6):1757–62.

    Article  PubMed  Google Scholar 

  171. Janeway KA, Pappo AS. Pediatric gastrointestinal stromal tumors. Hematol Oncol Clin North Am. 2009;23:15–34.

    Article  PubMed  Google Scholar 

  172. Champagne MA, Capdeville R, Krailo M, Qu W, Peng B, Rosamilia M, et al. Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children’s Oncology Group phase 1 study. Blood. 2004;104(9):2655–60.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Division of Pediatric Oncology, Hacettepe University Faculty of Medicine & Cancer Institute, Hacettepe University Oncology Hospital, Yenişehir, Ankara, Turkey

    M. Tezer Kutluk

  2. Department of Pediatrics, Division of Pediatric Oncology, University of Health Sciences, Gulhane Training and Research Hospital, Etlik/Kecioren, Ankara, Turkey

    Erman Ataş

Authors
  1. M. Tezer Kutluk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Erman Ataş
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medical Oncology, Hacettepe University Institute of Cancer, Sihhiye, Ankara, Turkey

    Suayib Yalcin

  2. Department of Oncology, Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA

    Philip A. Philip

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kutluk, M.T., Ataş, E. (2019). Gastrointestinal Cancers in Children. In: Yalcin, S., Philip, P. (eds) Textbook of Gastrointestinal Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-18890-0_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-18890-0_18

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-18888-7

  • Online ISBN: 978-3-030-18890-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation